Health Care: Drugs

Durata Therapeutics Inc (DRTX: NASDAQ)

$15.52 -0.97 | -5.88%
08/28/14 - 04:00 PM ET
Company Profile
Price and Volume
Recent Price 16.49
52 Week High 18.17
52 Week Low 8.10
Avg. Daily Vol. (Mil) 0.34
Beta (3 year) 3.54
Share Related Items
Mkt Cap (Mil) 441.56
Shares Out (Mil) 26.78
Float (Mil) 15.54
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 3.10
Current Ratio 3.80
LT Debt/ Equity 14.30
Total Debt / Equity 14.66
Valuation Ratios
Price Earnings n.a.
Price/Sales 0.00
Price/Book 161.86
Price/Cash Flow -6.80
Per Share Data
Earnings -2.45
Sales 0.00
Book Value 0.10
Cash Flow -2.43
Business Summary
Durata Therapeutics Inc is a development stage biopharmaceutical company. The Company, along with its subsidiaries, develops and commercializes novel therapeutics for patients with infectious diseases and acute illnesses.
General Information
200 South Wacker Drive
Suite 2550
Chicago, IL 60606
www.duratatherapeutics.com
Industry : Drugs
Sector: Health Care
Employees: 67
CEO: Mr. Paul R. Edick
Short Interest
Current Month (Mil) 2.98
Previous Month (Mil) 2.54
Short Interest Ratio (Days) 7.30
Management Effectiveness
Return on Equity n.a.
Return on Assets -82.30
Return on Investments -156.80
Profitability
Gross Margin n.a.
EBIT Margin n.a.
Profit Margin 0.00

Portfolios with DRTX

Latest DRTX Headlines from TheStreet

More Financial News for DRTX

Press Releases for DRTX

See All Press Releases

Partner Headlines for DRTX

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter